Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many sickle cell day centres have closed in the last 5 years; and how many sickle cell day centres remain operational.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure people with learning disabilities receive screenings for cervical cancer.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to its ambition to change the National Health Service so that it diagnoses earlier and treats faster. The NHS Cervical Screening Programme plays a vital role in this. Across the NHS, local systems and partnerships are working together to find ways to make cervical screening more accessible for people with a learning disability.
Following the launch of the Reasonable Adjustment Digital Flag Information Standard, NHS England is considering the role this digital flag has in further personalisation in the programme.
Reasonable adjustments can include:
Additionally, in early 2026, the NHS Cervical Screening Programme will be offering a self-testing kit to under-screened women, starting with those who are the most overdue for screening. This will help tackle deeply entrenched barriers that keep some away from screening.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential impact of domestic wood burning in residential areas on public health.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Chief Medical Officer’s 2022 Annual Report highlighted that domestic wood burning is a significant source of harmful fine particulate matter, particularly in residential areas.
The UK Health Security Agency’s (UKHSA’s) systematic reviews of the association between outdoor and indoor exposure to solid fuel burning and respiratory diseases have shown that burning solid fuels can contribute to the risk of chronic obstructive pulmonary disease and lung cancer in adults. The UKHSA’s reviews are available at the following two links:
https://pubmed.ncbi.nlm.nih.gov/35149281/
https://pubmed.ncbi.nlm.nih.gov/33017761/
Our 10-Year Health Plan for England sets out how the Government will improve the public's health, including action to reduce the health harms of air pollution, and in particular on domestic burning.
Asked by: John Grady (Labour - Glasgow East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that food products include labels on pea and legume allergies.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
There are a large number of potential food ingredients that may cause allergic reactions in sensitised individuals. The current 14 regulated allergens are recognised as the most common and potent allergens of public health concern across Europe. They must be clearly identified on prepacked foods and communicated effectively when eating out. Although peas and other legumes are not regulated allergens, they must still be declared in the ingredients list when they are intentionally used in any prepacked food products.
The Food Security Agency continues to work to make it easier for people with food hypersensitivities, such as allergies, intolerances, and coeliac disease, to have access to clear and accurate information which is a fundamental part of its work. Its research can be found at the following link:
https://www.food.gov.uk/research/food-hypersensitivity
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential factors that may prevent women from seeking diagnosis and referral for lipoedema; and what steps he is taking to ensure timely access to specialist assessment and treatment.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Women with lipoedema can face a number of barriers to seeking diagnosis and referral, including long waits, misdiagnosis, often as obesity or lymphoedema, and low awareness of the condition among both the public and some healthcare professionals. These factors can lead to delayed recognition, worsening symptoms, and reduced confidence in seeking care.
We recognise the need to improve awareness and understanding of lipoedema. To support earlier, more accurate diagnosis, the Royal College of General Practitioners (RCGP) has worked in partnership with Lipoedema UK to develop a dedicated e‑learning module for general practitioners, covering the presentation, pathophysiology, diagnosis, and management of lipoedema in primary care. This resource is freely available to RCGP members.
Access to specialist assessment and treatment for lipoedema is commissioned locally by integrated care boards, which are best placed to understand local population need. Treatment options may include compression therapy, simple lymphatic drainage, self‑management support and, in severe cases, consideration of liposuction in line with interventional procedures guidance published by the National Institute for Health and Care Excellence (NICE). Clinicians may offer treatment where appropriate, using their professional judgment and taking advice published by NICE into account.
We are aware that some European countries, including Germany, have expanded access to liposuction for lipoedema following emerging evidence from the German LiPLEG study into liposuction. In England, NICE’s current guidance advises that evidence on the safety and efficacy of liposuction for chronic lipoedema remains limited, and it should only be offered with appropriate clinical governance and safeguards. NICE will review this guidance once the full LiPLEG data is available.
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has considered adopting approaches to lipoedema treatment used by other European countries, like Germany and Spain.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Women with lipoedema can face a number of barriers to seeking diagnosis and referral, including long waits, misdiagnosis, often as obesity or lymphoedema, and low awareness of the condition among both the public and some healthcare professionals. These factors can lead to delayed recognition, worsening symptoms, and reduced confidence in seeking care.
We recognise the need to improve awareness and understanding of lipoedema. To support earlier, more accurate diagnosis, the Royal College of General Practitioners (RCGP) has worked in partnership with Lipoedema UK to develop a dedicated e‑learning module for general practitioners, covering the presentation, pathophysiology, diagnosis, and management of lipoedema in primary care. This resource is freely available to RCGP members.
Access to specialist assessment and treatment for lipoedema is commissioned locally by integrated care boards, which are best placed to understand local population need. Treatment options may include compression therapy, simple lymphatic drainage, self‑management support and, in severe cases, consideration of liposuction in line with interventional procedures guidance published by the National Institute for Health and Care Excellence (NICE). Clinicians may offer treatment where appropriate, using their professional judgment and taking advice published by NICE into account.
We are aware that some European countries, including Germany, have expanded access to liposuction for lipoedema following emerging evidence from the German LiPLEG study into liposuction. In England, NICE’s current guidance advises that evidence on the safety and efficacy of liposuction for chronic lipoedema remains limited, and it should only be offered with appropriate clinical governance and safeguards. NICE will review this guidance once the full LiPLEG data is available.
Asked by: Danny Chambers (Liberal Democrat - Winchester)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to develop a national infection strategy.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government already has evidence-based policies in place to embed system-wide infection prevention and control measures to mitigate the impact of infection.
For example, the National Infection Prevention and Control Manual (NIPCM) for England provides guidance on infection control for National Health Service healthcare staff of all disciplines in all care settings. The NIPCM, last updated in July 2025, is a live document that is updated in line with new evidence and lessons learned.
More broadly, the UK 5-year action plan for antimicrobial resistance (AMR) 2024 to 2029 contains targets and commitments to address rises in both infection and in antimicrobial prescribing that could arise as a consequence of infection. Further information on the UK 5-year action plan for AMR is available at the following link:
Asked by: Lord Harper (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to the answer by Baroness Merron on 16 December (HL Deb Col 661), (1) how many, and (2) what proportion of, NHS staff have taken up the offer of a flu vaccination this year; and how does that compare to each of the previous five years for (a) total NHS staff and (b) NHS staff by job category.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
For England, the UK Health Security Agency publishes monthly provisional vaccine uptake data for frontline healthcare workers (HCWs) from November to March. The most recent monthly data was published on 18 December 2025 and includes all vaccinations given between 1 September to 30 November 2025. For the 2025 to 2026, and 2024 to 2025 seasons HCWs have been eligible from 1 and 3 October respectively, rather than 1 September as in previous seasons. Data is therefore not comparable with seasons prior to 2024 to 2025.
Vaccine uptake data, both percentages and numbers vaccinated, is given at a national, regional, and trust level, with data by staff groups, as percentages, also given. For previous seasons the available data by staff group varies and some previous seasons have numbers vaccinated available. The table attached shows the seasonal influenza vaccine uptake amongst frontline HCWs in National Health Service trusts in England, at a national and staff group level, for vaccinations given between 1 September, where applicable, and 30 November, for the 2020 to 2026 seasons. The numbers vaccinated are based on response rates from NHS trusts and are not extrapolated to represent 100% of the data.
Final end of season vaccine uptake data is published in the annual reports in late spring and include data on staff groups. Annual reports include national level comparative data from 19 previous seasons.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what consideration he has given to improving information for parents and carers on the early symptoms of Type 1 Diabetes in young children.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service publishes information for patients and the public to support the understanding of the four key symptoms of type 1 diabetes. These are known as the four Ts: toilet, or frequent urination; thirsty, or constant thirst; tired, or low energy; and thinner, or unexplained weight loss. Further information on the symptoms is avaiable at the following link:
NHS England also hosts information provided by Diabetes UK about the symptoms of type 1 diabetes, which is avaiable at the following link:
NHS England is undertaking a review of options for improving information for parents and carers on the early symptoms of type 1 diabetes in young children and this will include engagement with relevant national organisations and partners.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people have been referred to Weightloss clinics within the last year.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Health Service and local government provide a range of services to help people living with overweight and obesity to manage their weight.
Integrated care boards are responsible for commissioning health services within their area in line with local population need and taking account of relevant guidance. This includes specialist weight management services, or weight loss clinics, for those living with severe obesity and associated health conditions.
The National Obesity Audit (NOA) aims to bring together existing comparable data from the different types of weight management services across England in order to drive improvement for the benefit of those living with overweight and obesity. Responsibility for the management and collection of referral data sits at a local system level, and not all providers of weight management services are submitting data into the NOA at present. It is therefore not possible to state how many people have been referred to weight loss clinics within the last year.
NHS England continues to develop the NOA with the aim of ensuring it will provide a comprehensive picture of activity, access to services, and health outcomes of patients using weight management services across England.